↓ Skip to main content

The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders

Overview of attention for article published in Frontiers in Pharmacology, June 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
32 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders
Published in
Frontiers in Pharmacology, June 2022
DOI 10.3389/fphar.2022.869606
Pubmed ID
Authors

Roberto Coccurello, Maria Cristina Marrone, Mauro Maccarrone

X Demographics

X Demographics

The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 11%
Other 4 11%
Student > Master 2 6%
Lecturer 1 3%
Student > Doctoral Student 1 3%
Other 4 11%
Unknown 20 56%
Readers by discipline Count As %
Medicine and Dentistry 5 14%
Neuroscience 4 11%
Nursing and Health Professions 2 6%
Unspecified 1 3%
Agricultural and Biological Sciences 1 3%
Other 3 8%
Unknown 20 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2024.
All research outputs
#2,279,423
of 26,591,670 outputs
Outputs from Frontiers in Pharmacology
#979
of 20,616 outputs
Outputs of similar age
#49,345
of 454,115 outputs
Outputs of similar age from Frontiers in Pharmacology
#43
of 1,302 outputs
Altmetric has tracked 26,591,670 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,616 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,115 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 1,302 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.